Scarica l'app Stockscreener
0.691
0.89%
-0.006
Aclarion Inc Borsa (ACON) Ultime notizie
Aclarion stock hits 52-week low at $0.61 amid steep decline - Investing.com
Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 90.7% in February - Defense World
Aclarion provides shareholder update, to file 10K by March-end -March 13, 2025 at 11:00 am EDT - Marketscreener.com
Aclarion, Inc. secures compliance with Nasdaq equity rule - Investing.com
Aclarion Provides Shareholder Update - The Manila Times
Aclarion Sets Major Corporate Update: 8-K Filed, 10-K Coming for AI Healthcare Pioneer - StockTitan
Aclarion announces expansion plans with RadNet affiliates in NY, NJ - MSN
Aclarion, a company using remote MRIs to assess back pain, expands in partnership with RadNet - Radiology Business
United States shares lower at close of trade; Dow Jones Industrial Average down 0.99% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.99% - Investing.com
Aclarion expands Nociscan access in New York, New Jersey - AuntMinnie
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey - The Globe and Mail
Aclarion to Expand Nociscan Access in New York, New Jersey -March 06, 2025 at 12:00 pm EST - Marketscreener.com
Aclarion Announces Expansion Plans With RadNet Affiliates In New York And New Jersey - Marketscreener.com
Aclarion stock hits 52-week low at $2.26 amid sharp annual decline - Investing.com Australia
Aclarion expands Nociscan sites in New York, New Jersey - Investing.com India
Aclarion shareholders approve stock issuance and charter amendment - Investing.com India
Dow Tumbles 1%; US Initial Jobless Claims Decline - Benzinga
Aclarion expands Nociscan sites in New York, New Jersey By Investing.com - Investing.com UK
Aclarion, Inc. Announces Expansion of Nociscan Access in New York and New Jersey to Address Chronic Low Back Pain - Nasdaq
Can This 97% Effective Spine Technology Transform RadNet's 112 Medical Centers? - StockTitan
Aclarion shareholders approve stock issuance and charter amendment By Investing.com - Investing.com UK
Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer' - Asianet Newsable
The amazing story behind Aclarion’s 126% stock surge and future prospects - Dataconomy
Aclarion Partners with Scripps Health to Bring Chronic Low Back Pain Solution to Southern California - HIT Consultant
Aclarion Expands Nociscan to Scripps Health, Advancing Chronic Low Back Pain Diagnostics in Southern California - Apna Kal
Why Aclarion (ACON) Shares Are Skyrocketing - Benzinga
Aclarion (NASDAQ: ACON) Soars on Scripps Health Partnership, Expanding Nociscan's Reach - Apna Kal
Aclarion to Provide Imaging Technology to Scripps Health in California; Shares Jump -March 03, 2025 at 09:33 am EST - Marketscreener.com
Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday? - Benzinga India
Aclarion (ACON) Shares Surge In Pre-Hour Trading Amid Key Healthcare Deal - Stocks Telegraph
Aclarion rises on commercial agreement with Scripps Health - TradingView
Aclarion Expands Access to Nociscan Technology Through Agreement with Scripps Health in San Diego Area - Nasdaq
Aclarion Announces First Commercial Agreement with Scripps Health - The Manila Times
How Aclarion's New Scripps Health Deal Could Transform Chronic Back Pain Diagnosis - StockTitan
LGVN To Complete ELPIS II Enrollment By Q2, Time To Keep An Eye On NXGL, What's The Buzz At ACON? - RTTNews
Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 1,730.4% in February - Defense World
Aclarion, Inc. Adjourns Special Meeting for More Votes - TipRanks
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders - The Manila Times
Aclarion Postpones Critical Stockholder VoteWill March 5 Meeting Secure Enough Support? - StockTitan
Aclarion stock hits 52-week low at $3.82 amid sharp annual decline - Investing.com Canada
Aclarion stock hits 52-week low at $3.82 amid sharp annual decline By Investing.com - Investing.com South Africa
(ACON) Technical Data - Stock Traders Daily
Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit - Yahoo Finance
Top 8 Must-See AI News Updates Investors Probably Missed - Insider Monkey
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit - EIN News
Aclarion Showcases NOCISCAN's Innovative Role in Chronic Low Back Pain Management at 2025 Spine Summit, Led by Dr. Nicholas Theodore - Nasdaq
Can This AI-Powered Technology Finally Solve the $300B Chronic Back Pain Crisis? - StockTitan
Aclarion secures patent for infection, pain biomarker detection - MSN
Short Interest in Aclarion, Inc. (NASDAQ:ACON) Decreases By 99.8% - Defense World
Aclarion receives U.S. patent on expanded applications of MRS data processing - MSN
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):